NEW DELHI: India on Sunday banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-19 infections, leading to a crippling shortages in many parts.
Authorities have blamed the ferocious resurgence of the virus mainly on crowding and a reluctance to wear masks.
Still, religious gatherings have continued and Prime Minister Narendra Modi and Home Minister Amit Shah have themselves addressed election campaigns attended by tens of thousands of people, many without masks and hardly any following social distancing.
As new COVID-19 cases surged to 152,879 on Sunday, the sixth record rise in seven days, harried relatives of patients made a kilometre-long queue to buy Remdesivir outside a big hospital in the western state of Gujarat, witnesses said.
India, known as the pharmacy of the world, has already stalled major exports of coronavirus vaccines though its supply too has run short in some states of the country.
In addition to the Remdesivir ban "till the situation improves", the health ministry said that manufacturers had been asked to step up supplies.
Seven India-based companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month, for local use and exports to more than 100 countries.
The companies are: Cipla, Dr. Reddy's Laboratories, Hetero Labs, Jubilant Life Sciences, Biocon's Syngene, Zydus Cadila Healthcare and the Indian unit of Mylan.
The World Health Organization in November issued a conditional recommendation against the use of Remdesivir in hospitalised patients, saying there was no evidence that the drug improved survival and other outcomes.
But many countries, including India, have continued its use.
India leads the world in the daily average number of new infections reported in more than two weeks, accounting for one in every six infections reported globally each day.
Deaths have also surged, with the health ministry reporting 839 fatalities on Sunday - the highest in more than five months - taking the total to 169,275.
India's tally of more than 13.35 million cases is the third-highest globally, behind the United States and Brazil. India's new infections have soared nearly 18-fold since hitting a multi-month low in early February.
BLACK MARKETING
Some state governments have in recent days raised concerns over hoarding and black marketing of Remdesivir, which in some instances is being sold at over 10 times the maximum retail price.
"Pharmacists and stockists might be doing black marketing and that needs to be checked," Rajesh Tope, health minister of India's hardest-hit Maharashtra state, told reporters this week.
Maharashtra and many other states have also demanded more vaccine doses. India has administered more than 100 million doses since mid-January, the most after the United States and China, but much lower than many countries per capita.
The federal health ministry has asked Maharashtra, home to India's financial capital Mumbai, to improve COVID-19 testing and deploy more manpower.
"Rostering of health care workers, hiring of contractual health workers need to be expedited," India's health secretary said, flagging an acute shortage of healthcare workers in seven districts of Maharashtra.
Thousands of people thronged the banks of the holy Ganges River in Haridwar city on Sunday for prayers during the Kumbh Mela - where up to five million are expected on certain days.
Authorities have made it mandatory for all people entering the area to take COVID-19 tests. But many devotees on Sunday gathered by the river without masks, in densely-packed crowds.
Reuters
Mon Apr 12 2021
A woman reacts as she receives a dose of COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, during the start of a four-day "Vaccination Festival" in Mumbai, India April 11, 2021. REUTERSpic
Isu stoking: Pengarah KK Mart, isteri akan kemuka representasi kepada AGC
Pengarah KK Mart yang berdepan dua pertuduhan melukakan perasaan orang Islam dalam isu berkaitan penjualan stoking tertera kalimah Allah akan mengemukakan representasi kepada Jabatan Peguam Negara.
Inisiatif IHH Healthcare lancar pemasangan panel solar wajar jadi contoh - Fadillah Yusof
IHH Healthcare Malaysia mencatatkan pencapaian baharu dengan melancarkan inisiatif pemasangan panel solar di seluruh rangkaian hospitalnya sekali gus menjadikannya pelopor.
Che'gu Bard akan didakwa di Johor Bahru esok
Che'gu Bard berkata, ia dipercayai berhubung kenyataannya mengenai isu kasino di Forest City, Johor.
Ahmad Zahid ucap tahniah kepada Farah Ain
Ahmad Zahid mengucapkan tahniah kepada atlet boling padang Nor Farah Ain Abdullah yang muncul juara pada Kejohanan Boling Padang Dalam Dewan Dunia 2024.
Raih RM31 juta sejak ditayangkan! Sheriff kini filem no. 1 di Malaysia
Berita gembira ini turut disokong oleh abang Syafiq, Syamsul Yusof yang turut bangga dengan kejayaan naskhah yang dihasilkan adiknya.
Letupan bom Sungai Golok: PDRM tingkat kawalan keselamatan sempadan Malaysia-Thailand
PDRM mempertingkatkan kawalan keselamatan di sempadan Malaysia-Thailand susulan insiden letupan bom dan bunyi tembakan di Sungai Golok.
Pemain ragbi meninggal dunia selepas perlawanan pasukan pilihan MB Kedah
Seorang bekas pemain Sukma Kedah meninggal dunia selepas menyertai perlawanan pertunjukan pasukan pilihan Menteri Besar Kedah pada Ahad.
OCC: Masih banyak usaha perlu dibuat dalam isu hak kanak-kanak
Masih banyak yang perlu dilakukan kerana Malaysia masih ketinggalan berbanding negara lain dalam menangani isu penderaan dan masalah sosial melibatkan kanak-kanak.
iPad Pro mungkin dijana dengan cip Apple M4 terbaharu, fokus ciri AI
Cip Apple M4 dijangka memfokuskan kepada keupayaan enjin neural yang disertakan bersama dengannya membolehkan ia menawarkan ciri AI yang lebih baik.
Lebih 840,000 permohonan untuk London Marathon 2025 pecah rekod dunia
Jumlah permohonan untuk menyertai larian TCS London Marathon tahun depan telah memecahkan rekod dunia.
Ini 5 jenis ubat masih dalam kajian, berpotensi rawat COVID-19
Namun, adakah ubat-ubatan yang sesetengah daripadanya didakwa mampu merawat musuh halimunan ini betul-betul berkesan?
COVID-19: KKM kaji kesan ubat Remdesivir, akan maklum kepada WHO
KKM akan memberi maklum balas kepada Pertubuhan Kesihatan Sedunia (WHO) berhubung penggunaan ubat tersebut.
COVID-19: AS umum guna ubat Remdesivir rawat pesakit parah
Pihak berkuasa Amerika Syarikat (AS) mula membenarkan penggunaan ubat Remdesivir yang masih dalam kajian untuk merawat pesakit COVID-19 semasa kecemasan.
COVID-19: Antiviral Remdesivir akan diperkenalkan - KP Kesihatan
Ubat antiviral baharu, Remdesivir, akan diperkenalkan untuk merawat pesakit COVID-19 di negara ini.
Tiga jenis ubat boleh diguna rawat COVID-19 - KP Kesihatan
Semakan pangkalan data produk berdaftar Bahagian Regulatori Farmasi Negara (NPRA) Kementerian Kesihatan (KKM) mendapati tiga jenis ubat itu berdaftar dengan Pihak Berkuasa Kawalan Dadah.
5 topik untuk sembang hari ini
Sebelum memulakan hari anda, berikut lima berita penting perlu anda tahu.
Potensi penyembuhan melalui antiviral koronavirus
China pada Khamis memulakan ujian klinikal ke atas 500 pesakit koronavirus (2019-nCoV) menggunakan ubat Remdesivir, antiviral yang dipercayai berpotensi menyembuhkan penyakit itu.